Solxama is right, your first point regarding CPA is not true and dangerous advice. CPA is actually an extremely potent progestogen, and by this mechanism, it potently surpresses the HPT axis. CPA is a moderately potent antiandrogen, so in order to make use of it's AA effects, you'd need to dose higher (the range you suggested). However, the risk for hyperprolactinemia increases in this range. CPA should probably only be used as progestogen to surpress HPTA, and not as AA. You could throw in a low dose Bica to block the little androgens you'd still have left after low dose CPA.
Your other points are correct, all the pharmaceuticals mentioned are not intended for long term use at such dosages (except in the case of cancer patients, which are, on average, much older and likely won't have decades to go relying on those drugs). Finasteride is the exception (although there is no real long term data available either).